BNA’s Health Care Daily Report™ sets the standard for reliable, high-intensity coverage of breaking health care news, covering all major legal, policy, industry, and consumer developments in a...
July 19 — The Republican party platform reads like a wish list of traditional Republican health-care goals, but notably omits two of Donald Trump's most controversial health-care ideas—allowing Medicare to negotiate drug prices and drugs to be imported.
The platform, unveiled July 18, includes familiar Republican language about making premium support an option for Medicare beneficiaries and turning Medicaid into a block grant system. It talks about repealing the Affordable Care Act, and has some broad ideas on what could replace it.
But notably, the platform doesn't mention allowing Medicare to negotiate drug prices, or importing drugs from overseas, two key ideas that the presumptive Republican nominee has backed throughout the primary process.
The platform isn't very specific, but most closely resembles the health-care plan put forward by House Speaker Paul Ryan (R-Wis.) in June, rather than the ideas espoused by the Trump campaign. The Ryan plan, released June 23, is meant to be a blueprint for conservatives to follow should they have control of both Congress and the White House (121 HCDR, 6/23/16).
Julius Hobson Jr., a senior policy adviser for Polsinelli PC in Washington, told Bloomberg BNA it appears the Trump campaign took a back seat in the crafting of the health portion of the platform.
“I don’t see this as any different than what Ryan and company have been pushing. There's not enough detail to show how legislation will be crafted, nor should anyone expect there to be,” Hobson told Bloomberg BNA July 19. He added there's “more detail in platform than we’ve ever heard out of Trump’s mouth. He’s just not been a candidate of specifics and won’t be nailed down on specifics. ”
Yet just because the platform doesn't mention Trump's specific issues, doesn't mean Trump won't continue to talk about them.
“It's clear that Trump won’t stick to his script,” Dan Mendelson, president of the consulting firm Avalere Health, told Bloomberg BNA July 19. “As a platform, it gives him the flexibility to get into more detail as he likes.”
Hobson said he also doesn't think the platform will limit Trump in any way. Trump hasn't hesitated to criticize members of his own party who disagree with him, and if he becomes president, he could have an especially caustic relationship with Congress, Hobson said.
“Drug prices negotiation and re-importation are two shining examples of where he’d have friction with his own party,” Hobson said.
Some early examples of that friction may already be playing out. During a panel discussion at the Republicans' convention in Cleveland on July 19, House Ways and Means Committee Chairman Kevin Brady (R-Texas) said congressional Republicans wouldn't agree to let Medicare negotiate prescription drug prices.
“Study after study shows that that will save no money,” Brady said. “There's a simple reason. If you follow the [Department of Veterans Affairs drug pricing] model, which is what's proposed for Medicare, this is how they save money: They don't allow breakthrough drugs, that may be more expensive, so they limit the medicines that are available, and they limit how veterans can get them. They limit access.”
Mendelson of Avalere told Bloomberg BNA the platform leaves a lot of flexibility for Trump to get into the details of his health policy during the general election campaign— if he wants to.
Trump has run his presidential campaign on a platform of very little policy experience, which could open the door for Congress to set the policy agenda when it comes to replacing the ACA. Policy experts and former Republican officials have said Ryan's plan could have a major impact—if Trump chooses to endorse it (111 HCDR, 6/9/16).
“I think this platform reflects the thinking in the House. Ryan has a very close relationship with the Republican policy elite, so that’s where the thinking is likely to concentrate even if Trump wins,” Mendelson said July 19.
Like Ryan's plan, the platform calls for an immediate repeal of the ACA.
“[A] Republican president, on the first day in office, will use legitimate waiver authority under the law to halt its advance and then, with the unanimous support of Congressional Republicans, will sign its repeal,” the platform states.
It blames Obamacare for high drug prices, and promises “price transparency” for consumers. The platform says the ACA imposed almost $30 billion in taxes over the past decade and its cost-shifting raised prices for drugs purchased in the private market.
“To simplify the system for both patients and providers, we will reduce mandates and enable insurers and providers of care to increase healthcare options and contain costs.”
The platform also promises tort reform to curb medical malpractice lawsuits against physicians, and calls for reforming the Food and Drug Administration to cut down on red tape in order to speed drug approvals.
“The FDA needs to return to its traditional emphasis on hard science and approving new breakthrough medicines, rather than divert its attention and consume its resources trying to overregulate electronic health records or vaping,” the platform states.
To contact the reporter on this story: Nathaniel Weixel in Washington at email@example.com
To contact the editor responsible for this story: Brian Broderick at firstname.lastname@example.org
Text of the 2016 Republican platform is at http://src.bna.com/gWm.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)